Viewing Study NCT04393350


Ignite Creation Date: 2025-12-24 @ 4:57 PM
Ignite Modification Date: 2026-01-29 @ 6:30 PM
Study NCT ID: NCT04393350
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-02-26
First Post: 2020-05-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Perioperative Lenvatinib With Pembrolizumab in Patients With Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma
Sponsor: Emory University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Kidney Cancer View
None Stage III Renal Cell Cancer AJCC v8 View
None Stage IV Renal Cell Cancer AJCC v8 View
Keywords: